The Superdisintegrants Market is gaining traction as pharmaceutical manufacturers increasingly focus on improving tablet performance, dissolution, bioavailability, and patient convenience. The market size is projected to reach US$ 0.89 billion by 2031, up from US$ 0.50 billion in 2023, registering a CAGR of 7.60% during 2023–2031. Rising demand for immediate-release formulations, orally...